Premium
Lakewood-Amedex Biotherapeutics Inc (LABT)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
Lakewood-Amedex Biotherapeutics, Inc. operates as a clinical-stage biotechnology company that develops antimicrobial products in the United States. The company offers products from its Bisphosphocin class, a novel class of antimicrobial agents a broad range of infections, including those affecting t... Lakewood-Amedex Biotherapeutics, Inc. operates as a clinical-stage biotechnology company that develops antimicrobial products in the United States. The company offers products from its Bisphosphocin class, a novel class of antimicrobial agents a broad range of infections, including those affecting the skin, bladder, and lungs. It also develops Nu-3, a topical antimicrobial for infected diabetic foot ulcers, which is in Phase 2b clinical trial. The company was formerly known as Lakewood-Amedex Inc. and changed its name to Lakewood-Amedex Biotherapeutics, Inc. in June 2025. Lakewood-Amedex Biotherapeutics, Inc. was incorporated in 2006 and is headquartered in University Park, Florida. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.368901 | -49.265625 | 0.7488 | 0.7741 | 0.366 | 360123 | 0.6614951 | CS |
| 4 | -0.373101 | -49.5486055777 | 0.753 | 0.8181 | 0.366 | 448755 | 0.69224241 | CS |
| 12 | -5.440101 | -93.4725257732 | 5.82 | 6.0565 | 0.366 | 2683894 | 2.1730341 | CS |
| 26 | -5.440101 | -93.4725257732 | 5.82 | 6.0565 | 0.366 | 2683894 | 2.1730341 | CS |
| 52 | -5.440101 | -93.4725257732 | 5.82 | 6.0565 | 0.366 | 2683894 | 2.1730341 | CS |
| 156 | -5.440101 | -93.4725257732 | 5.82 | 6.0565 | 0.366 | 2683894 | 2.1730341 | CS |
| 260 | -5.440101 | -93.4725257732 | 5.82 | 6.0565 | 0.366 | 2683894 | 2.1730341 | CS |
Transactions différées
Pour obtenir des transactions en temps réel, améliorez votre compte
Passer à la version en temps réel| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
